Home > News > Nanobiotech Pioneers Predict Nanomedicine Impact within Five Years
February 11th, 2004
Nanobiotech Pioneers Predict Nanomedicine Impact within Five Years
With nanobiotech research growing at an astounding rate - and funds starting to follow - what are the most promising near-term prospects for nanomedicine? Predicting which applications will have the resources - and luck - to succeed is a dicey proposition, experts acknowledge. But NanoBiotech News posed the questions to the field's preeminent pioneers and found that real-world applications of nanomedicine will happen within five years. Ground-breaking nanotechnology researcher Ralph C. Merkle, Ph.D., and the father of nanomedicine Robert A. Freitas, Jr., JD, are among the industry heavyweights who weighed in with NanoBiotech News on the state of the science and where it's headed.
Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014
European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014
Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014
Tuning light to kill deep cancer tumors: Nanoparticles developed at UMass Medical School advance potential clinical application for photodynamic therapy October 15th, 2014